Caprock Group, Inc. Horizon Therapeutics Public LTD CO Transaction History

Caprock Group, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 23, 2023	BUY	$62.39 - $113.8 $111,303 - $203,019	1,784 New	1,784 $0
Q2 2022 Jul 26, 2022	SELL	$79.4 - $116.36 $155,544 - $227,949	-1,959 Closed	0 $0
Q1 2022 Apr 12, 2022	BUY	$86.42 - $109.81 $6,308 - $8,016	73 Added 3.87%	1,959 $0
Q4 2021 Jan 18, 2022	SELL	$98.56 - $119.91 $25,428 - $30,936	-258 Reduced 12.03%	1,886 $203,000
Q3 2021 Oct 07, 2021	BUY	$91.91 - $110.37 $735 - $882	8 Added 0.37%	2,144 $235,000
Q2 2021 Aug 13, 2021	BUY	$86.24 - $95.92 $184,208 - $204,885	2,136 New	2,136 $200,000
Q1 2021 Apr 29, 2021	SELL	$71.83 - $95.48 $327,185 - $434,911	-4,555 Closed	0 $0
Q3 2020 Oct 29, 2020	SELL	$55.23 - $79.93 $93,891 - $135,881	-1,700 Reduced 27.18%	4,555 $354,000
Q2 2020 Aug 05, 2020	SELL	$30.2 - $56.98 $137,077 - $258,632	-4,539 Reduced 42.05%	6,255 $348,000
Q1 2020 Apr 28, 2020	SELL	$24.87 - $38.56 $9,127 - $14,151	-367 Reduced 3.29%	10,794 $320,000
Q4 2019 Feb 04, 2020	SELL	$25.43 - $36.67 $3,814 - $5,500	-150 Reduced 1.33%	11,161 $404,000
Q3 2019 Oct 31, 2019	SELL	$23.0 - $27.97 $22,885 - $27,830	-995 Reduced 8.09%	11,311 $308,000
Q2 2019 Jul 23, 2019	BUY	$22.81 - $28.48 $280,699 - $350,474	12,306 New	12,306 $296,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Caprock Group, Inc. with notifications on news.